Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Neuroblastoma 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Biphenotypic, Acute 1Heart Failure 1Ganglioneuroblastoma 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1Blast Crisis 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 2dapagliflozin 2Rituximab 2pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1acalabrutinib 1Vincristine 1Valsartan 1Trastuzumab 1Standard of Care 1Specimen Handling 1Pyruvic Acid 1Prednisolone 1Practice Guidelines as Topic 1Ogivri 1Mesenchymal Stem Cell Transplantation 1Lenalidomide 1Eplerenone 1Electronic Health Records 1Echocardiography 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Cardiac Resynchronization Therapy 1Angiotensin-Converting Enzyme Inhibitors 1Adrenergic beta-Antagonists 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Heart Failure × Dexrazoxane × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡